Preclinical and phase I studies with rhizoxin to apply a pharmacokinetically guided dose-escalation scheme.
about
Multicentre phase II pharmacological evaluation of rhizoxin. Eortc early clinical studies (ECSG)/pharmacology and molecular mechanisms (PAMM) groupsPhase II clinical trials with rhizoxin in breast cancer and melanoma. The EORTC Early Clinical Trials Group.Bacterial endosymbiosis is widely present among zygomycetes but does not contribute to the pathogenesis of mucormycosisAntiproliferative effects of ester- and amide-functionalized rhizoxin derivatives.
P2860
Preclinical and phase I studies with rhizoxin to apply a pharmacokinetically guided dose-escalation scheme.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Preclinical and phase I studie ...... guided dose-escalation scheme.
@en
type
label
Preclinical and phase I studie ...... guided dose-escalation scheme.
@en
prefLabel
Preclinical and phase I studie ...... guided dose-escalation scheme.
@en
P2093
P356
P1476
Preclinical and phase I studie ...... guided dose-escalation scheme.
@en
P2093
A Setanoians
M A Graham
T Hamilton
P304
P356
10.1093/JNCI/84.7.494
P407
P577
1992-04-01T00:00:00Z